Table 1

Median eligible and included discharges per hospital per year

			All hospitals		COTH teaching hospitals		Non-COTH teaching hospitals		Non-teaching hospitals
			Total	Included	Total	Included	Total	Included	Total	Included
AMI-1	Aspirin at arrival	Median	242	192	305	241	123	95	92	66
AMI-1	Aspirin at arrival	(IQR)	(111, 362)	(92, 288)	(220, 435)	(186, 384)	(87, 255)	(51, 194)	(54, 189)	(38, 158)
AMI-8a	PCI within 90 min	Median	242	25	305	28	123	12	92	10
AMI-8a	PCI within 90 min	(IQR)	(111, 362)	(11, 40)	(220, 435)	(20, 44)	(87, 255)	(0, 29)	(54, 189)	(0, 25)
AMI-2	Aspirin at discharge	Median	242	197	305	255	123	71	92	62
AMI-2	Aspirin at discharge	(IQR)	(111, 362)	(72, 308)	(220, 435)	(184, 377)	(87, 255)	(35, 195)	(54, 189)	(22, 138)
AMI-3	ACEi/ARB for LVSD	Median	242	34	305	49	123	13	92	9
AMI-3	ACEi/ARB for LVSD	(IQR)	(111, 362)	(14, 57)	(220, 435)	(33, 73)	(87, 255)	(8, 30)	(54, 189)	(3, 20)
AMI-5	β-blocker at discharge	Median	242	191	305	246	123	71	92	60
AMI-5	β-blocker at discharge	(IQR)	(111, 362)	(71, 294)	(220, 435)	(173, 358)	(87, 255)	(34, 196)	(54, 189)	(23, 134)
AMI-10	Statin at discharge	Median	251	203	308	257	130	76	90	49
AMI-10	Statin at discharge	(IQR)	(116, 374)	(80, 313)	(223, 418)	(183, 368)	(80, 231)	(34, 183)	(52, 177)	(19, 110)

ACEi, ACE inhibitor; AMI, acute myocardial infarction; ARB, angiotensin receptor blocker; COTH, Council of Teaching Hospitals; LVSD, left ventricular systolic dysfunction; PCI, percutaneous coronary intervention.